The therapeutic potential of HER2–ADC in PDX models, such as gallbladder cancer, which poses a significant threat to patients and requires capturing its heterogeneity to investigate new treatment strategies, warrants further exploration. The gene discussed is ERBB2; the disease is gallbladder cancer.